BioCentury
ARTICLE | Financial News

AnaptysBio raises $40M in series D

July 16, 2015 1:19 AM UTC

Antibody play AnaptysBio Inc. (San Diego, Calif.) raised $40 million in an oversubscribed series D round. BVF Partners and its affiliates; Cormorant Asset Management; Frazier Healthcare; HBM Healthcare Investments; Longwood Capital Partners; and Novo A/S (Hellerup, Denmark) participated, along with other undisclosed investors. ...